Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy.

Moldofsky H, Broughton RJ, Hill JD.

Sleep Med. 2000 Apr 1;1(2):109-116.

PMID:
10767651
3.

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.

Broughton RJ, Fleming JA, George CF, Hill JD, Kryger MH, Moldofsky H, Montplaisir JY, Morehouse RL, Moscovitch A, Murphy WF.

Neurology. 1997 Aug;49(2):444-51.

PMID:
9270575
4.

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy.

Mitler MM, Harsh J, Hirshkowitz M, Guilleminault C.

Sleep Med. 2000 Jul 1;1(3):231-243.

PMID:
10828434
6.

Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.

Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W.

Sleep. 2002 Dec;25(8):905-9.

PMID:
12489899
7.
8.

Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies.

Thorpy MJ, Schwartz JR, Kovacevic-Ristanovic R, Hayduk R.

Psychopharmacology (Berl). 2003 Jun;167(4):380-5. Epub 2003 Apr 23.

PMID:
12709775
9.

Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness.

Schwartz JR, Nelson MT, Schwartz ER, Hughes RJ.

Clin Neuropharmacol. 2004 Mar-Apr;27(2):74-9. Erratum in: Clin Neuropharmacol. 2004 May-Jun;27(3):152.

PMID:
15252267
10.

Modafinil in the treatment of excessive daytime sleepiness in children.

Ivanenko A, Tauman R, Gozal D.

Sleep Med. 2003 Nov;4(6):579-82.

PMID:
14607353
11.

Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy.

Becker PM, Schwartz JR, Feldman NT, Hughes RJ.

Psychopharmacology (Berl). 2004 Jan;171(2):133-9. Epub 2003 Nov 25.

PMID:
14647965
13.

Treatment modalities for narcolepsy.

Fry JM.

Neurology. 1998 Feb;50(2 Suppl 1):S43-8. Review.

PMID:
9484423
14.

The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.

Black J, Pardi D, Hornfeldt CS, Inhaber N.

Sleep Med. 2009 Sep;10(8):829-35. doi: 10.1016/j.sleep.2009.05.004. Epub 2009 Jul 18.

PMID:
19616998
15.
16.

Placebo and modafinil effect on sleepiness in obstructive sleep apnea.

Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, Tufik S.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):552-9. Epub 2007 Oct 30.

PMID:
18053628
17.

Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.

Talbot K, Stradling J, Crosby J, Hilton-Jones D.

Neuromuscul Disord. 2003 Jun;13(5):357-64.

PMID:
12798791
18.
19.

Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.

McClellan KJ, Spencer CM.

CNS Drugs. 1998 Apr;9(4):311-24. doi: 10.2165/00023210-199809040-00006.

PMID:
27521015
20.

Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease.

Adler CH, Caviness JN, Hentz JG, Lind M, Tiede J.

Mov Disord. 2003 Mar;18(3):287-93.

PMID:
12621632

Supplemental Content

Support Center